[Form 4] BCB Bancorp Inc (NJ) Insider Trading Activity

Rhea-AI Filing Summary

BCB Bancorp (BCBP) filed a Form 4 reporting a routine equity incentive granted to Chief Executive Officer and director Michael A. Shriner. On 02/24/2025 he received an option to purchase 26,942 common shares at an exercise price of $9.91, expiring 02/24/2035. The award vests 1/3 per year beginning on the first anniversary of the grant date.

No open-market purchase or sale of common stock was disclosed in Table I. After the reported transaction Shriner directly owns 33,500 common shares and 26,942 derivative securities (the new option). Ownership is shown as direct, and the filing was submitted by a single reporting person.

The transaction is an internal compensation event with no immediate cash movement or change to outstanding share count; therefore, its impact on BCB Bancorp’s capital structure and near-term financials is minimal.

Insights

Financial Analyst

TL;DR: Standard CEO option grant; limited investor impact and no cash outlay.

The filing documents an at-market option grant to incentivize the CEO. Such awards are customary and do not signal buying or selling pressure. While the option could introduce modest future dilution, 26.9k shares represent a small fraction of BCBP’s total shares outstanding, so dilution risk is negligible. There are no sales, purchases, or red flags disclosed. Overall, the event is immaterial to valuation and should be viewed as neutral from a governance and capital-allocation standpoint.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

SHRINER MICHAEL A

(Last) (First) (Middle)

591-595 AVENUE C

(Street)

BAYONNE NJ 07002

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
BCB BANCORP INC [ BCBP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/24/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock								33,500	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option to purchase	$9.91	02/24/2025		M		26,942		02/24/2026(1)	02/24/2035	Common Stock	26,942	$0	26,942	D

Explanation of Responses:

1. Stock options vest at the rate of 1/3 per year commencing on the first anniversary of the grant date.

	/s/ Michael A. Shriner, by Edward Hogan, attorney-in-fact	08/01/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did BCBP CEO Michael Shriner report on Form 4?

He received an option to buy 26,942 BCBP shares at $9.91, expiring 02/24/2035.

How many BCB Bancorp shares does the CEO own after the transaction?

Shriner now directly owns 33,500 common shares plus the new option for 26,942 shares.

When do the newly granted BCBP options vest?

The options vest in equal one-third installments beginning one year after the 02/24/2025 grant date.

Is there any common-stock sale or purchase disclosed in this Form 4?

No. The filing shows only the issuance of derivative securities (stock options), with no share sales or purchases.

Does the option grant materially affect BCB Bancorp’s share count?

The 26,942-share option is small relative to total outstanding shares, so potential dilution is minimal.